Fifth Eye’s software is designed to act as an early warning system to predict when a patient might be in imminent trouble, based on their electrocardiogram (ECG) data. When the heart overcompensates for other trouble in the body, the signs are subtle, Baird says, but they have detectable mathematical characteristics, which helps the company’s software to assess the patient’s condition.

Read the full article >

Fifth Eye uses continuous physiologic waveforms to build clinical early warning systems that enable proactive patient care to improve outcomes, avoid adverse events, shorten lengths of stay and reduce healthcare costs. The financing will be used to secure FDA clearance of Fifth Eye’s first product, support clinical studies with multiple health systems, and enable commercial launch of the company’s first product, the Analytic for Hemodynamic Instability.

Read the full article >

“Despite continued advances in healthcare technology, clinicians do not have adequate tools that allow them to consistently identify patients prior to rapid worsening of their clinical condition,” Tom Shehab, a physician and managing partner at Arboretum, told Crain’s. “The Fifth Eye technology has the potential to provide early warning of hemodynamic collapse (and) allows clinicians the opportunity to intervene and improve patient outcomes.”

Read the full article >

Jen Baird, a serial entrepreneur who has led several Michigan-based healthcare technology startups, is back at it with Fifth Eye, an Ann Arbor, MI-based company developing software that performs analytics on patient data. Investors so far like what they see in the young venture: Fifth Eye has just raised $2.3 million in seed funding from Invest Michigan, the Biosciences Research and Commercialization Center at Western Michigan University, and 33 angel investors.

Read the full article >

Readings from a single ECG sensor might soon be able to predict when a patient is going to “crash,” thanks to technology developed by the University of Michigan’s Integrative Research in Critical Care group and spun out into a new company, Ann Arbor-based Fifth Eye Inc.

Read the full article >

ANN ARBOR—When University of Michigan researchers started getting spontaneous hugs from nurses while testing their system that monitors the autonomic nervous system of hospital patients and predicts problems, they knew they were on to something.

Read the full article >

ANN ARBOR – Fifth Eye Inc., a digital health predictive analytics company, has received a $2.36 million investment from Invest Michigan, Biosciences Research and Commercialization Center, and 33 private angel investors.

Read the full article >

A serial entrepreneur with a long record of raising substantial sums of money for early-stage technology companies, Jennifer Baird has closed on a seed-funding round of $2.36 million for her newest venture, Ann Arbor-based Fifth Eye Inc., a spinoff from the University of Michigan.

Read the full article >